EMA Authorised: Ovitrelle (choriogonadotropin alfa) — Merck Europe B.V.

View source ↗

Summary

The EMA authorised Ovitrelle (choriogonadotropin alfa) for triggering ovulation in women undergoing assisted reproductive techniques for infertility; the market…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulation
• Infertility

Drugs mentioned

• Ovitrelle (choriogonadotropin alfa)

Snippet

Status: Authorised. Therapeutic area: Anovulation;Reproductive Techniques, Assisted;Infertility, Female. MAH: Merck Europe B.V.. Decision date: 23/05/2025